A Liébana
About
In The Last Decade
A Liébana
18 papers receiving 357 citations
Peers
Comparison fields: 5 of 51
- Cardiology and Cardiovascular Medicine 233
- Nephrology 136
- Epidemiology 74
- Internal Medicine 58
- Pulmonary and Respiratory Medicine 56
Countries citing papers authored by A Liébana
This map shows the geographic impact of A Liébana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Liébana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Liébana more than expected).
Fields of papers citing papers by A Liébana
This network shows the impact of papers produced by A Liébana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Liébana. The network helps show where A Liébana may publish in the future.
Co-authorship network of co-authors of A Liébana
This figure shows the co-authorship network connecting the top 25 collaborators of A Liébana. A scholar is included among the top collaborators of A Liébana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Liébana. A Liébana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 8 | |
| 3 | 16 | |
| 4 | 55 | |
| 5 | 100 | |
| 6 | 8 | |
| 7 | [Incidence and risk factors for non-traumatic lower extremity amputation in hemodialysis patients]. | 11 |
| 8 | [Doxazosine associated to renin-angiotensin blockers and calcioantagonists in chronic renal failure patients]. | 1 |
| 9 | 41 | |
| 10 | [Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?]. | 15 |
| 11 | [Lercanidipine in diabetic patients with renal failure]. | 11 |
| 12 | [Health-related quality of life in elderly patients in haemodialysis]. | 19 |
| 13 | 57 | |
| 14 | [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients]. | 2 |
| 15 | [Platelet antiaggregation and hemorrhagic risk in hemodialysis]. | 8 |
| 16 | [Rhabdomyolysis and acute renal failure secondary to statins]. | 2 |
| 17 | [A comparison of phosphorus-chelating effect of calcium carbonate versus calcium acetate before dialysis]. | 9 |
| 18 | [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass]. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.